COVID-19 vaccination using mRNA technology began at the end of 2020 in several countries, approximately 9 months after the WHO declared the new coronavirus a pandemic, and began in Japan at the end of February 2021. Several studies have reported FDG avidity in enlarged axillary lymph nodes as a specific feature of FDG-PET/CT imaging after COVID-19 vaccination. A major concern is that this finding could lead to a misdiagnosis in patients with various types of malignancy. We review the impact of COVID-19 vaccination on the management of patients scheduled for FDG-PET/CT in the setting of nationwide mass vaccination.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239370 | PMC |
| http://dx.doi.org/10.35772/ghm.2021.01076 | DOI Listing |
Publication Analysis
Top Keywords
covid-19 vaccination
16
fdg-pet/ct imaging
8
vaccination
5
effects covid-19
4
vaccination fdg-pet/ct
4
imaging literature
4
literature review
4
review covid-19
4
vaccination mrna
4
mrna technology
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!